Drug profile

The FDA adverse-event record for Gentamicin+Mometasone Furoate+Posaconazole

Name: Gentamicin+Mometasone Furoate+Posaconazole - FDA Animal Adverse Event Reports
Creator: PlainBreed
License: https://creativecommons.org/publicdomain/zero/1.0/

13 FDA reports name Gentamicin+Mometasone Furoate+Posaconazole, a lower-volume drug in the CVM extract. Species, reactions, and outcomes follow.

#2248 of 2,679
by report volume (all drugs): 13
adverse-event reports: 0.0%
death-coded share: Dog
most-reported species

Compiled by PlainBreed

Verify with FDA CVM →

Corpus placement

According to the FDA Center for Veterinary Medicine openFDA adverse-event extract, Gentamicin+Mometasone Furoate+Posaconazole ranks #2210 of 2679 by total reports (13). Death-coded-share rank requires at least 50 reports. National dual: Milbemycin Oxime + Spinosad is #1 of 2679 drugs by total adverse-event reports (149,624) at death-coded-share rank 965 of 1130 drugs with at least 50 reports (2.3%); separately, Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) is #1 highest death-coded share at 97.8% (report rank #821).

149,624
Milbemycin Oxime + Spinosad reports (#1): 97.8%
Atlantic Salmon Transgenic Whole (Opafp-Ghc2 Rdna Construct Inserted Into The A-Locus In The Eo-1A Lineage) death share (#1): #2210
This drug, reports of 2679

Report volume reflects how common a breed or drug is and how often owners and vets file — not actual risk. Death-coded share ranks are limited to entries with enough reports to be meaningful. The two maps do not agree at #1.

Release-over-release change

What changed in the latest FDA data snapshot

PlainBreed reconstructed the prior snapshot from dated openFDA partitions through 2025 Q4, then compared it with the 2026-07-27 openFDA export. Gentamicin+Mometasone Furoate+Posaconazole has 13 reports now versus 10 in that prior snapshot: 3 more (30.0%).

Report change: +3
Death-coded reports: +0
Death-coded share: +0.0 pts

This compares reported-event counts in two source snapshots. It does not establish a change in real-world risk, product safety, or disease incidence.

Subscribe to Gentamicin+Mometasone Furoate+Posaconazole changes

Signature read: Gentamicin+Mometasone Furoate+Posaconazole's 0.0% death-coded share is among the lowest in the openFDA drug corpus.

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

0.0%

Death-coded share of reports

Active Ingredients

Gentamicin+Mometasone Furoate+Posaconazole

Administration Routes

Auricular (Otic)Unknown

Species Affected

Dog 13

Most Affected Breeds

Pointing Dog - German Short-haired 2

Shepherd Dog - Anatolian 2

Retriever - Golden 1

Retriever - Labrador 1

Terrier - West Highland White 1

Poodle (unspecified) 1

Bulldog - French 1

Crossbred Canine/dog 1

Collie - Border 1

Mountain Dog - Bernese 1

Most Reported Reactions

Lack of efficacy - NOS 3

Leucocytosis NOS 2

Lethargy (see also Central nervous system depression in Neurological) 2

Diarrhoea 2

Elevated alanine aminotransferase (ALT) 2

Head shake - ear disorder 2

Vomiting bile 2

Rectal haemorrhage 1

Sneezing 1

Nasal bleeding 1

Eye haemorrhage 1

Thrombocytopenia 1

Outcome Breakdown

Outcome Unknown

8 (61.5%)

Ongoing

5 (38.5%)

Gentamicin+Mometasone Furoate+Posaconazole: low death-coded share in the FDA AER row

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

What to do with this drug

Read how death-coded share differs from a mortality rate before drawing conclusions. Understanding adverse events
Browse the full drug directory to compare report counts across products. All drugs

A report does not prove a drug caused the reaction; consult a veterinarian before acting on this data.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

openFDA Animal & Veterinary Adverse Events (FDA CVM) for Gentamicin+Mometasone Furoate+Posaconazole (#2248 of 2,679 by report volume); death-coded 0.0%. PlainBreed drug row · death-coded share stamp 0.0% · vintage 2025.

Informational only. FDA adverse-event reports are voluntary and do not prove causation; consult a veterinarian before acting on them. Verify with FDA CVM →